Kraft Group returned to back the biotechnology company's second financing round, taking its equity capital to $56m in less than 18 months.
US-based biotechnology company Scholar Rock secured $36m today in a series B round featuring diversified conglomerate Kraft Group.
Fidelity Management and Research Company led the round, which also featured Cormorant Asset Management, Polaris Partners, Arch Venture Partners, EcoR1 Capital and Scholar Rock founder Timothy Springer.
Scholar Rock is developing biologic therapies related to the molecular mechanisms of supracellular activation in order to treat a range of diseases by preventing growth in the disease microenvironment.
The company raised $20m in a…
